Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Performance of Interleukin-27 Cord Blood Level as A Biomarker Predicating Early Onset Neonatal Sepsis

NCT05589909 is registered in ClinicalTrials.gov with Mansoura University Children Hospital as lead sponsor.

NCT NCT05589909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05589909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Performance of Interleukin-27 Cord Blood Level as A Biomarker Predicating Early Onset Neonatal Sepsis
Lead sponsor
Mansoura University Children Hospital
Phase
Observational
Overall status
Unknown status
Start date
June 20, 2022
Completion date
January 1, 2023
Enrollment
548 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neonatal sepsis, early-onset